Showing results (371-380 of 743) with videos related to
Sort By:
Pageof 75
Blood|October 6, 2016
Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomibShaji K Kumar, Betsy R LaPlant, Craig B Reeder, et al.Blood Advances|June 23, 2022
Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosisEli Muchtar, Morie A Gertz, Betsy R LaPlant, et al.Mayo Clinic Proceedings|August 8, 2015
Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus StatementAngela Dispenzieri, Francis Buadi, Shaji K Kumar, et al.American Journal of Hematology|June 2, 2017
The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myelomaToshi Ghosh, Wilson I Gonsalves, Dragan Jevremovic, et al.Cancer|June 19, 2012
Ten-year survival after autologous stem cell transplantation for immunoglobulin light chain amyloidosisStefan Cordes, Angela Dispenzieri, Martha Q Lacy, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2022
Optimizing Thromboembolism Prophylaxis for the Contemporary Age of Multiple MyelomaMuhamed Baljevic, Douglas W Sborov, Ming Y Lim, et al.Journal of Vascular and Interventional Radiology : JVIR|April 26, 2023
Percutaneous Cryoablation of Plasmacytomas: Oncologic Effectiveness and Adverse EventsGrant D Schmit, A Nicholas Kurup, Johnathan M Morris, et al.Blood Cancer Journal|January 9, 2020
Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysisRahma Warsame, Betsy LaPlant, Shaji K Kumar, et al.American Journal of Hematology|March 5, 2020
Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemiaLaura A Evans, Dragan Jevremovic, Bharat Nandakumar, et al.Blood Cancer Journal|December 14, 2020
Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patientsAlissa Visram, Abdullah S Al Saleh, Harsh Parmar, et al.Pageof 75